Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells

Hematopoietic stem cell
DOI: 10.1126/scitranslmed.aaf9336 Publication Date: 2016-10-12T18:18:14Z
ABSTRACT
Hematopoietic stem cells from patients with sickle cell disease can be edited by CRISPR/Cas9 and maintain the edits in vivo.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (57)
CITATIONS (404)